Ruzanna Papyan: Intersection of Germline Predisposition and Pediatric Oncology Clinical Care and Research
Ruzanna Papyan, Pediatric Oncologist and clinical research physician at the Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:
“Curious about how germline cancer predisposition is shaping the future of pediatric oncology?
Don’t miss this important upcoming event!
This interactive symposium is open to clinicians, researchers, trainees, and allied health professionals working in — or interested in — the care of children and young adults with hereditary cancer risk.
Join the St. Jude Symposium:
“At the Crossroads: Intersection of Germline Predisposition and Pediatric Oncology Clinical Care and Research”.
- Date: October 14–15, 2025
- Location: In-person and virtual
- Free registration
- Register now
- More information.
- Advanced Genomic Sequencing for hereditary cancer diagnosis.
- Precision Medicine in targeted and organ-sparing therapies.
- Ethical & Psychosocial Considerations in genetic testing.
- Survivorship Strategies for at-risk youth.
- Expanding Global Access to genetic services.
A great opportunity to learn, connect, and collaborate across the global pediatric oncology community!
More information.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023